A Phase I Study Of The Vascular Disrupting Combretastatin, OXi4503, In Patients With Relapsed and Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)
| Autor: | Turner, Daniel *, Gonzalez, Andres *, Pettiford, Leslie *, Meacham, Amy *, Wise, Elizabeth *, Bosse, Raphael C *, Chaplin, Dai *, Hsu, Jack W., Brown, Randy A, Hiemenz, John W *, Norkin, Maxim, Wingard, John R *, Cogle, Christopher R |
|---|---|
| Zdroj: | In Blood 15 November 2013 122(21):1463-1463 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|